Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 12;60(1):141.
doi: 10.3390/medicina60010141.

The Prognostic Value of One-Year Changes in Biventricular Mechanics for Three-Year Survival in Patients with Precapillary Pulmonary Hypertension: A Cardiovascular Magnetic Resonance Feature Tracking Study

Affiliations

The Prognostic Value of One-Year Changes in Biventricular Mechanics for Three-Year Survival in Patients with Precapillary Pulmonary Hypertension: A Cardiovascular Magnetic Resonance Feature Tracking Study

Lina Padervinskienė et al. Medicina (Kaunas). .

Abstract

Background and Objectives: The management of patients with pulmonary hypertension (PH) poses a considerable challenge. While baseline cardiac magnetic resonance imaging (cMRI) indices are recognized for survival prognosis in PH, the prognostic value of one-year changes in biventricular mechanics, especially as assessed using feature tracking (FT) technology, remains underexplored. This study aims to assess the predictive value of one-year change in cMRI-derived biventricular function and mechanics parameters, along with N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and six-minute walking test (6MWT) results for three-year mortality in precapillary PH patients. Materials and Methods: In this retrospective study, 36 patients diagnosed with precapillary pulmonary hypertension (mPAP 55.0 [46.3-70.5] mmHg, pulmonary capillary wedge pressure 10.0 [6.0-11.0] mmHg) were included. Baseline and one-year follow-up cMRI assessments, clinical data, and NT-proBNP levels were analyzed. FT technology was utilized to assess biventricular strain parameters. Patients were categorized into survival and non-survival groups based on three-year outcomes. Statistical analyses, including univariate logistic regression and Cox regression, were performed to identify predictive parameters. Results: The observed three-year survival rate was 83.3%. Baseline right ventricle (RV) ejection fraction (EF) was significantly higher in the survival group compared to non-survivors (41.0 [33.75-47.25]% vs. 28.0 [23.5-36.3]%, p = 0.044), and values of ≤32.5% were linked to a 20-fold increase in mortality risk. RV septum longitudinal strain (LS) and RV global LS exhibited significant improvement over a one-year period in the survival group compared to the non-survival group (-1.2 [-6.4-1.6]% vs. 4.9 [1.5-6.7]%, p = 0.038 and -3.1 [-9.1-2.6]% vs. 4.5 [-2.1-8.5]%, p = 0.048, respectively). Declines in RV septum LS by ≥2.95% and in RV GLS by ≥3.60% were associated with a 25-fold and 8-fold increase in mortality risk, respectively. Conclusions: The decrease in right ventricular septal and global longitudinal strain over a one-year period demonstrates a significant predictive value and an association with an increased three-year mortality risk in patients with precapillary PH.

Keywords: cardiac magnetic resonance; feature tracking; pulmonary hypertension; right ventricle.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Receiver operating characteristic (ROC) curves of (a) baseline RV EF ≤ 32.5%, (b) RV septum LS Δ ≥ 2.95%, and (c) RV GLS Δ ≥ 3.60%. RV—right ventricle; GLS—global longitudinal strain, LS—longitudinal strain, EF—ejection fraction.
Figure 2
Figure 2
Kaplan–Meier curve estimation of the time to death according to (a) baseline RV EF ≤ 32.5%, (b) RV septum LS Δ ≥ 2.95%, (c) RV GLS Δ ≥ 3.60%. RV—right ventricle, GLS—global longitudinal strain, LS—longitudinal strain, EF—ejection fraction.

References

    1. Humbert M., Kovacs G., Hoeper M.M., Badagliacca R., Berger R.M.F., Brida M., Carlsen J., Coats A.J.S., Escribano-Subias P., Ferrari P., et al. 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. Eur. Heart J. 2022;43:3618–3731. doi: 10.1093/eurheartj/ehac237. - DOI - PubMed
    1. Naeije R., Manes A. The Right Ventricle in Pulmonary Arterial Hypertension. Eur. Respir. Rev. 2014;23:476. doi: 10.1183/09059180.00007414. - DOI - PMC - PubMed
    1. Alabed S., Shahin Y., Garg P., Alandejani F., Johns C.S., Lewis R.A., Condliffe R., Wild J.M., Kiely D.G., Swift A.J. Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. JACC Cardiovasc. Imaging. 2021;14:931–942. doi: 10.1016/j.jcmg.2020.08.013. - DOI - PMC - PubMed
    1. Swift A.J., Rajaram S., Campbell M.J., Hurdman J., Thomas S., Capener D., Elliot C., Condliffe R., Wild J.M., Kiely D.G. Prognostic Value of Cardiovascular Magnetic Resonance Imaging Measurements Corrected for Age and Sex in Idiopathic Pulmonary Arterial Hypertension. Circ. Cardiovasc. Imaging. 2014;7:100–106. doi: 10.1161/CIRCIMAGING.113.000338. - DOI - PubMed
    1. Kallifatidis A., Mouratoglou S.A., Giannakoulas G., Finitsis S., Karvounis H., Sianos G. Myocardial Deformation Assessment in Patients with Precapillary Pulmonary Hypertension: A Cardiac Magnetic Resonance Study. Diagn. Interv. Imaging. 2021;102:153–161. doi: 10.1016/j.diii.2020.08.001. - DOI - PubMed